Amyloid-β-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption

International Journal of Molecular Medicine

Volumn 31, Issue 5, 2013, Pages 1105-1112

  Cao, Lining ^a   Wang, Hao ^a   Wang, Fang ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

4 aminophenylmercuric acetate; Age related macular degeneration; Barrier integrity; GM6001; Matrix metalloproteinase 9; RNA interference; Tight junction

Indexed keywords

4 AMINOPHENYLMERCURIC ACETATE; AMYLOID BETA PROTEIN; F ACTIN; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; OCCLUDIN; PROTEIN ZO1; SMALL INTERFERING RNA; TIGHT JUNCTION PROTEIN; VISUAL PIGMENT;

ARTICLE; CELL DISRUPTION; CHRONIC INFLAMMATION; ELECTRIC RESISTANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PERMEABILITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RNA INTERFERENCE; ZYMOGRAPHY;

ADULT; AMYLOID BETA-PEPTIDES; CELL DEATH; CELL SHAPE; DIPEPTIDES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PHENYLMERCURIC ACETATE; PROTEIN STRUCTURE, QUATERNARY; RETINAL PIGMENT EPITHELIUM; RNA, SMALL INTERFERING; TIGHT JUNCTION PROTEINS;

EID: 84876152671     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1310     Document Type: Article

References (37)

1. Klein R, Peto T, Bird A and Vannewkirk MR: The epidemiology of age-related macular degeneration. Am J Ophthalmol 137: 486-495, 2004.
2. Johnson LV, Forest DL, Banna CD, et al: Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci USA 108: 18277-18282, 2011.
3. Luibl V, Isas JM, Kayed R, Glabe CG, Langen R and Chen J: Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest 116: 378-385, 2006.
4. Mullins RF, Russell SR, Anderson DH and Hageman GS: Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14: 835-846, 2000.
5. Isas JM, Luibl V, Johnson LV, et al: Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci 51: 1304-1310, 2010.
6. Wang J, Ohno-Matsui K, Yoshida T, et al: Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. J Cell Physiol 220: 119-128, 2009.
7. Wang J, Ohno-Matsui K, Yoshida T, et al: Altered function of factor I caused by amyloid beta: Implication for pathogenesis of age-related macular degeneration from drusen. J Immunol 181: 712-720, 2008.
8. Kurji KH, Cui JZ, Lin T, et al: Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 51: 1151-1163, 2010.
9. Streilein JW: Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 5: 428-432, 1993.
10. Jo DH, Kim JH and Kim JH: How to overcome retinal neuropathy: The fight against angiogenesis-related blindness. Arch Pharm Res 33: 1557-1565, 2010.
11. Cunha-Vaz J, Bernardes R and Lobo C: Blood-retinal barrier. Eur J Ophthalmol 21: 3-9, 2010.
12. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ and Cheetham ME: Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 675-684, 2004.
13. Peng S, Gan G, Rao VS, Adelman RA and Rizzolo LJ: Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 53: 5016-5028, 2012.
14. Liu J, Jin X, Liu KJ and Liu W: Matrix metalloproteinase2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci 32: 3044-3057, 2012.
15. Martins T, Baptista S, Gonçalves J, et al: Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: Role of tight junction proteins and matrix metalloproteinase-9. Brain Res 1411: 28-40, 2011.
16. Bruban J, Glotin AL, Dinet V, et al: Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 8: 162-177, 2009.
17. Maminishkis A, Chen S, Jalickee S, et al: Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 47: 3612-3624, 2006.
18. Suzuki T, Yoshinaga N and Tanabe S: Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286: 31263-31271, 2011.
19. Feng S, Cen J, Huang Y, et al: Matrix metalloproteinase-2 and-9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One 6: E20599, 2011.
20. Bauer AT, Bürgers HF, Rabie T and Marti HH: Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30: 837-848, 2010.
21. Manicone AM and McGuire JK: Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19: 34-41, 2008.
22. Jonas JB, Tao Y, Neumaier M and Findeisen P: Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol 90: E381-e388, 2012.
23. Ecker SM, Pfahler SM, Hines JC, Lovelace AS and Glaser BM: Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration. Mol Vis 18: 1658-1667, 2012.
24. Jeong S, Ledee DR, Gordon GM, et al: Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am J Pathol 180: 2028-2039, 2012.
25. Huet E, Vallée B, Delbé J, et al: EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: Implications in dry eye disease. Am J Pathol 179: 1278-1286, 2011.
26. Pflugfelder SC, Farley W, Luo L, et al: Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 166: 61-71, 2005.
27. Kayed R, Head E, Thompson JL, et al: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489, 2003.
28. Giebel SJ, Menicucci G, McGuire PG and Das A: Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85: 597-607, 2005.
29. Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ and Chong NV: Plasma levels of matrix metalloproteinase-2 and-9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye 22: 855-859, 2008.
30. Chen W, Stambolian D, Edwards AO, et al: Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 107: 7401-7406, 2010.
31. Balda MS, Gonzalez-Mariscal L, Contreras RG, et al: Assembly and sealing of tight junctions: Possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 122: 193-202, 1991.
32. Bandyopadhyay M and Rohrer B: Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement. Invest Ophthalmol Vis Sci 53: 1953-1961, 2012.
33. Kook SY, Hong HS, Moon M, Ha CM, Chang S and Mook-Jung I: Aβ1-42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca?+-calcineurin signaling. J Neurosci 32: 8845-8854, 2012.
34. Thibault O, Gant JC and Landfield PW: Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: Minding the store. Aging Cell 6: 307-317, 2007.
35. Grolla AA, Fakhfouri G, Balzaretti G, et al: Aβ leads to Ca2+ signaling alterations and transcriptional changes in glial cells. Neurobiol Aging 34: 511-522, 2013.
36. Kuchibhotla KV, Lattarulo CR, Hyman BT and Bacskai BJ: Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323: 1211-1215, 2009.
37. Kobayashi T, Hattori S, Nagai Y and Tajima S: Differential regulation of the secretions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 from human keratinocytes in culture. IUBMB Life 50: 221-226, 2000.